- Home
- LNTH vs CMA Comparison
LNTH vs CMA Comparison
Compare LNTH & CMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- CMA
- Stock Information
- Founded
- LNTH 1956
- CMA 1849
- Country
- LNTH United States
- CMA United States
- Employees
- LNTH N/A
- CMA N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CMA Major Banks
- Sector
- LNTH Health Care
- CMA Finance
- Exchange
- LNTH Nasdaq
- CMA Nasdaq
- Market Cap
- LNTH 7.5B
- CMA 7.1B
- IPO Year
- LNTH 2015
- CMA N/A
- Fundamental
- Price
- LNTH $77.61
- CMA $58.56
- Analyst Decision
- LNTH Strong Buy
- CMA Hold
- Analyst Count
- LNTH 5
- CMA 20
- Target Price
- LNTH $133.80
- CMA $62.95
- AVG Volume (30 Days)
- LNTH 1.3M
- CMA 1.6M
- Earning Date
- LNTH 05-07-2025
- CMA 04-21-2025
- Dividend Yield
- LNTH N/A
- CMA 4.85%
- EPS Growth
- LNTH N/A
- CMA 4.95
- EPS
- LNTH 3.53
- CMA 5.29
- Revenue
- LNTH $1,536,699,000.00
- CMA $3,234,000,000.00
- Revenue This Year
- LNTH $5.81
- CMA $7.32
- Revenue Next Year
- LNTH $12.26
- CMA $3.12
- P/E Ratio
- LNTH $22.69
- CMA $11.04
- Revenue Growth
- LNTH 12.53
- CMA N/A
- 52 Week Low
- LNTH $74.34
- CMA $45.32
- 52 Week High
- LNTH $126.89
- CMA $73.45
- Technical
- Relative Strength Index (RSI)
- LNTH 26.85
- CMA 62.18
- Support Level
- LNTH $78.61
- CMA $54.42
- Resistance Level
- LNTH $83.60
- CMA $59.36
- Average True Range (ATR)
- LNTH 3.75
- CMA 1.09
- MACD
- LNTH -3.08
- CMA 0.72
- Stochastic Oscillator
- LNTH 0.35
- CMA 87.70
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About CMA Comerica Incorporated
With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.